Infliximab Pharmacokinetics Are Influenced by Intravenous Immunoglobulin Administration in Patients With Kawasaki Disease
Clinical Pharmacokinetics - United Kingdom
doi 10.1007/s40262-018-0653-6
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 5, 2018
Authors
Publisher
Springer Science and Business Media LLC